Table 2.
Cardio-cerebrovascular functional modulation of phthalides.
Cardio-cerebr-ovascular functions | Phthalides | Possible mechanisms | Reference |
---|---|---|---|
Angiogenesis or neovascularization | Ligustilide | Increase cerebral vessels number, VEGF and eNOS activation | [17] |
Butylphthalide | Alter Ang-1/Ang-2/Tie-2 signaling axis | [88] | |
Butylphthalide | Promote VEFG and Ang-1, and upregulate sonic hedgehog expression | [89] | |
Butylidenephthalide | Enhance VEGF and BDNF expressions via activation of AKT/mTOR signal pathway | [90] | |
Protection on endothelial cells | Ligustilide | Stimulate NRF2/ARE pathway | [91] |
Butylphthalide | Maintain the endothelial PGC-1α expression via regulating eNOS activity | [92] | |
Butylidenephthalide | Elevate the pool of PI species, and inhibit the phosphorylation of PLCλ and ERK1/2 | [93] | |
Levistilide A | Suppress NLRP3 gene expression by blocking the Syk–p38/JNK pathway | [94] | |
Z,Z′-3a.7a′,7a.3a′-dihydroxyligustilide | Increase the viability and proliferation of HUVECs, and reduce the apoptosis | [95] | |
Smooth muscle relaxation, inhibition of VSMCs abnormal proliferation and migration | Ligustilide | Downregulate c-Myc/MMP2 signaling pathway and ROCK-JNK signaling pathway | [96] |
Butylphthalide | Inhibit the β-catenin signaling pathway | [97] | |
Butylidenephthalide | Phosphorylate JNK and p38 MAPK, and upregulate Nur77 gene | [98] | |
Vasodilatation or vasorelaxation activities | Ligustilide | Inhibit [Ca2+] influx and cold-sensing protein TRPM8 and TRPA1 | [99] |
Butylphthalide | Increase the regional blood flow by preventing vasoconstriction of the artery and maintaining its diameter at normal level | [100] | |
Senkyunolide A | Inhibit RYRs and VDCCs | [101] | |
Anti-arthrosclerosis effects | Ligustilide and Senkyunolide A | Inhibit CD137 expression through suppressing AP-1 and AKT/NF-κB signaling pathway | [102] |
Ligustilide | Activate Nrf2/HO-1 induction and NO synthesis | [103] | |
Ligustilide | Activate Nrf2 and ARE-driven genes | [91] | |
Anti-thrombotic effects | Butylphthalide | Inhibit human platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and PDE | [104] |
(S)-ZJM-289, a nitric oxide-releasing derivative of 3-n-butylphthalide | Maintain mitochondrial integrity and function, and block mitochondria-mediated cell death possibly by upregulation of Hsp70 | [105] | |
3-Butyl-2-benzothiophen-1(3H)-one (5d) | Decrease NADPH oxidase activity by promoting Nrf2 nuclear localization through PI3K/Akt signaling pathway | [106] | |
Anti-myocardial ischemia effects | Ligustilide and Cnidilide | Reduce serum lactic acid and free fatty acid | [107] |
Butylphthalide | Inhibit inflammatory and oxidative stress responses by regulating the Akt/Nrf2 signaling pathway | [108] | |
Butylidenephthalide | Target the PI3K/STAT3 axis | [12] |